MiRNA and miRNA target genes in copy number variations occurring in individuals with intellectual disability

BMC Genomics

Volumn 14, Issue 1, 2013, Pages

  Qiao, Ying ^a   Badduke, Chansonette ^a   Mercier, Eloi ^b   Lewis, Suzanne M E ^a   Pavlidis, Paul ^b   Rajcan Separovic, Evica ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Copy number variant regions (CNVRs); Copy number variants (CNVs); Functional pathways; Intellectual disabilities (ID); Micro RNA (miRNA)

Indexed keywords

MICRORNA;

ARTICLE; BIOINFORMATICS; BRAIN FUNCTION; CONTROLLED STUDY; COPY NUMBER VARIATION; DEVELOPMENTAL DISORDER; DISEASE CLASSIFICATION; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE TARGETING; GENETIC DATABASE; GENETIC PREDISPOSITION; GENOMICS; HUMAN; INTELLECTUAL IMPAIRMENT; MAJOR CLINICAL STUDY; POPULATION GENETICS; PREVALENCE; RNA GENE;

CASE-CONTROL STUDIES; COGNITION; DATABASES, GENETIC; DNA COPY NUMBER VARIATIONS; FEMALE; GENOMICS; HUMANS; INTELLECTUAL DISABILITY; MALE; MICRORNAS;

EID: 84881130124     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-14-544     Document Type: Article

References (48)

1. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854. 10.1016/0092-8674(93)90529-Y, 8252621.
2. Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993, 75:855-862. 10.1016/0092-8674(93)90530-4, 8252622.
3. Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 2005, 6:376-385.
4. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20. 10.1016/j.cell.2004.12.035, 15652477.
5. Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, Lim B, Rigoutsos I. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 2006, 126:1203-1217. 10.1016/j.cell.2006.07.031, 16990141.
6. Vasudevan S. Posttranscriptional upregulation by microRNAs. Wiley Interdiscip Reviews 2011, 3:311-330.
7. Sethupathy P, Collins FS. MicroRNA target site polymorphisms and human disease. Trends Genet 2008, 24:489-497. 10.1016/j.tig.2008.07.004, 18778868.
8. Duan S, Mi S, Zhang W, Dolan ME. Comprehensive analysis of the impact of SNPs and CNVs on human microRNAs and their regulatory genes. RNA Biol 2009, 6:412-425. 10.4161/rna.6.4.8830, 2783774, 19458495.
9. Felekkis K, Voskarides K, Dweep H, Sticht C, Gretz N, Deltas C. Increased number of microRNA target sites in genes encoded in CNV regions. Evidence for an evolutionary genomic interaction. Mol Biol Evol 2011, 28:2421-2424. 10.1093/molbev/msr078, 21441354.
10. Marcinkowska M, Szymanski M, Krzyzosiak WJ, Kozlowski P. Copy number variation of microRNA genes in the human genome. BMC Genomics 2011, 12:183. 10.1186/1471-2164-12-183, 3087710, 21486463.
11. Schiffman JD, Lorimer PD, Rodic V, Jahromi MS, Downie JM, Bayerl MG, Sanmann JN, Althof PA, Sanger WG, Barnette P, et al. Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression. Brit J Haematol 2011, 155:477-486.
12. Shim SM, Nam HY, Lee JE, Kim JW, Han BG, Jeon JP. MicroRNAs in human lymphoblastoid cell lines. Crit Rev Eukar Gene 2012, 22:189-196.
13. Bandiera S, Hatem E, Lyonnet S, Henrion-Caude A. microRNAs in diseases: from candidate to modifier genes. Clinical genetics 2010, 77:306-313. 10.1111/j.1399-0004.2010.01370.x, 20132241.
14. Esteller M. Non-coding RNAs in human disease. Nature reviews 2011, 12:861-874. 10.1038/nrg3074, 22094949.
15. Ghahramani Seno MM, Hu P, Gwadry FG, Pinto D, Marshall CR, Casallo G, Scherer SW. Gene and miRNA expression profiles in autism spectrum disorders. Brain research 2011, 1380:85-97.
16. Provost P. MicroRNAs as a molecular basis for mental retardation, Alzheimer's and prion diseases. Brain research 2010, 1338:58-66. 2896967, 20347722.
17. Talebizadeh Z, Butler MG, Theodoro MF. Feasibility and relevance of examining lymphoblastoid cell lines to study role of microRNAs in autism. Autism Res 2008, 1:240-250. 10.1002/aur.33, 2768334, 19360674.
18. Bian S, Sun T. Functions of noncoding RNAs in neural development and neurological diseases. Mol Neurobiol 2011, 44:359-373. 10.1007/s12035-011-8211-3, 3246283, 21969146.
19. Willemsen MH, Valles A, Kirkels LA, Mastebroek M, Olde Loohuis N, Kos A, Wissink-Lindhout WM, de Brouwer AP, Nillesen WM, Pfundt R, et al. Chromosome 1p21.3 microdeletions comprising DPYD and MIR137 are associated with intellectual disability. J Med Genet 2011, 48:810-818. 10.1136/jmedgenet-2011-100294, 22003227.
20. de Pontual L, Yao E, Callier P, Faivre L, Drouin V, Cariou S, Van Haeringen A, Genevieve D, Goldenberg A, Oufadem M, et al. Germline deletion of the miR-17 approximately 92 cluster causes skeletal and growth defects in humans. Nature genetics 2011, 43:1026-1030. 10.1038/ng.915, 3184212, 21892160.
21. Vaishnavi V, Manikandan M, Tiwary BK, Munirajan AK. Insights on the functional impact of MicroRNAs present in autism-associated copy number variants. PloS one 2013, 8:e56781. 10.1371/journal.pone.0056781, 3581547, 23451085.
22. Kosik KS. The neuronal microRNA system. Nat Rev Neurosci 2006, 7:911-920. 10.1038/nrn2037, 17115073.
23. Szulwach KE, Jin P, Alisch RS. Noncoding RNAs in mental retardation. Clinical genetics 2009, 75:209-219. 10.1111/j.1399-0004.2008.01134.x, 3270373, 19159391.
24. Ritchie W, Flamant S, Rasko JE. mimiRNA: a microRNA expression profiler and classification resource designed to identify functional correlations between microRNAs and their targets. Bioinformatics (Oxford, England) 2010, 26:223-227.
25. Betel D, Koppal A, Agius P, Sander C, Leslie C. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome biology 2010, 11:R90. 10.1186/gb-2010-11-8-r90, 2945792, 20799968.
26. Wu X, Zhang D, Li G. Insights into the regulation of human CNV-miRNAs from the view of their target genes. BMC Genomics 2012, 13:707. 10.1186/1471-2164-13-707, 3582595, 23244579.
27. Aoki Y, Niihori T, Narumi Y, Kure S, Matsubara Y. The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders. Hum Mutat 2008, 29:992-1006. 10.1002/humu.20748, 18470943.
28. Houge G, Rasmussen IH, Hovland R. Loss-of-function CNKSR2 mutation is a likely cause of non-syndromic X-linked intellectual disability. Mol Syndromol 2012, 2:60-63. 3326275, 22511892.
29. McMillan EL, Kamps AL, Lake SS, Svendsen CN, Bhattacharyya A. Gene expression changes in the MAPK pathway in both Fragile X and down syndrome human neural progenitor cells. Am J Stem Cells 2012, 1:154-162. 3399245,3399245, 22822472.
30. Shaw-Smith C, Pittman AM, Willatt L, Martin H, Rickman L, Gribble S, Curley R, Cumming S, Dunn C, Kalaitzopoulos D, et al. Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability. Nat Genet 2006, 38:1032-1037. 10.1038/ng1858, 16906163.
31. Nowakowska BA, Obersztyn E, Szymanska K, Bekiesinska-Figatowska M, Xia Z, Ricks CB, Bocian E, Stockton DW, Szczaluba K, Nawara M, et al. Severe mental retardation, seizures, and hypotonia due to deletions of MEF2C. Am J Med Genet B Neuropsychiatr Genet 2010, 153B:1042-1051.
32. Zweier M, Gregor A, Zweier C, Engels H, Sticht H, Wohlleber E, Bijlsma EK, Holder SE, Zenker M, Rossier E, et al. Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression. Hum Mutat 2010, 31:722-733. 10.1002/humu.21253, 20513142.
33. Quintero-Rivera F, Sharifi-Hannauer P, Martinez-Agosto JA. Autistic and psychiatric findings associated with the 3q29 microdeletion syndrome: case report and review. Am J Med Genet 2010, 152A:2459-2467. 10.1002/ajmg.a.33573, 20830797.
34. Garcia-Orti L, Cristobal I, Cirauqui C, Guruceaga E, Marcotegui N, Calasanz MJ, Castello-Cros R, Odero MD. Integration of SNP and mRNA arrays with microRNA profiling reveals that MiR-370 is upregulated and targets NF1 in acute myeloid leukemia. PLoS One 2012, 7:e47717. 10.1371/journal.pone.0047717, 3471844, 23077663.
35. Doxakis E. Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J Biol Chem 2010, 285:12726-12734. 10.1074/jbc.M109.086827, 2857101, 20106983.
36. Wang H, Liu J, Zong Y, Xu Y, Deng W, Zhu H, Liu Y, Ma C, Huang L, Zhang L, et al. miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-beta type II receptor. Brain Res 2010, 1357:166-174.
37. Xu XL, Zong R, Li Z, Biswas MH, Fang Z, Nelson DL, Gao FB. FXR1P but not FMRP regulates the levels of mammalian brain-specific microRNA-9 and microRNA-124. J Neurosci 2011, 31:13705-13709. 10.1523/JNEUROSCI.2827-11.2011, 3446782, 21957233.
38. Gibson WT, Harvard C, Qiao Y, Somerville MJ, Lewis ME, Rajcan-Separovic E. Phenotype-genotype characterization of alpha-thalassemia mental retardation syndrome due to isolated monosomy of 16p13.3. Am J Med Genet 2008, 146A:225-232. 10.1002/ajmg.a.32056, 18076105.
39. Harvard C, Malenfant P, Koochek M, Creighton S, Mickelson EC, Holden JJ, Lewis ME, Rajcan-Separovic E. A variant Cri du Chat phenotype and autism spectrum disorder in a subject with de novo cryptic microdeletions involving 5p15.2 and 3p24.3-25 detected using whole genomic array CGH. Clin Genet 2005, 67:341-351. 10.1111/j.1399-0004.2005.00406.x, 15733271.
40. Tyson C, Harvard C, Locker R, Friedman JM, Langlois S, Lewis ME, Van Allen M, Somerville M, Arbour L, Clarke L, et al. Submicroscopic deletions and duplications in individuals with intellectual disability detected by array-CGH. Am J Med Genet 2005, 139:173-185.
41. Tyson C, McGillivray B, Chijiwa C, Rajcan-Separovic E. Elucidation of a cryptic interstitial 7q31.3 deletion in a patient with a language disorder and mild mental retardation by array-CGH. Am J Med Genet 2004, 129A:254-260. 10.1002/ajmg.a.30245, 15326624.
42. Rajcan-Separovic E, Harvard C, Liu X, McGillivray B, Hall JG, Qiao Y, Hurlburt J, Hildebrand J, Mickelson EC, Holden JJ, et al. Clinical and molecular cytogenetic characterisation of a newly recognised microdeletion syndrome involving 2p15-16.1. J Med Genet 2007, 44:269-276. 10.1136/jmg.2006.045013, 2598046, 16963482.
43. Firth HV, Richards SM, Bevan AP, Clayton S, Corpas M, Rajan D, Van Vooren S, Moreau Y, Pettett RM, Carter NP. DECIPHER: database of chromosomal imbalance and phenotype in humans using ensembl resources. Am J Hum Genet 2009, 84:524-533. 10.1016/j.ajhg.2009.03.010, 2667985, 19344873.
44. Fan YS, Jayakar P, Zhu H, Barbouth D, Sacharow S, Morales A, Carver V, Benke P, Mundy P, Elsas LJ. Detection of pathogenic gene copy number variations in patients with mental retardation by genomewide oligonucleotide array comparative genomic hybridization. Hum Mutat 2007, 28:1124-1132. 10.1002/humu.20581, 17621639.
45. Qiao Y, Tyson C, Hrynchak M, Lopez-Rangel E, Hildebrand J, Martell S, Fawcett C, Kasmara L, Calli K, Harvard C, et al. Clinical application of 2.7M cytogenetics array for CNV detection in subjects with idiopathic autism and/or intellectual disability. Clin Genet 2013, 83:145-154. 10.1111/j.1399-0004.2012.01860.x, 22369279.
46. Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic acids research 2011, 39:D152-157. 10.1093/nar/gkq1027, 3013655, 21037258.
47. Goecks J, Nekrutenko A, Taylor J. Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol 2010, 11:R86. 10.1186/gb-2010-11-8-r86, 2945788, 20738864.
48. Zhang B, Kirov S, Snoddy J. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 2005, 33:W741-748. 10.1093/nar/gki475, 1160236, 15980575.